Akso Health Group Reports Delayed Annual Filing, CEO Signature Ensures Compliance.

Akso Health Group has delayed its annual report filing due to a need for additional time to review and finalize financial statements. The company expects to file the report within 15 calendar days of the original due date and there are no anticipated significant changes in financial results from the previous fiscal year.

Akso Health Group ADR (AHG) has announced a delay in filing its annual report, citing the need for additional time to review and finalize financial statements. The company expects to submit the report within 15 calendar days of the original due date. There are no anticipated significant changes in financial results from the previous fiscal year [1].

The delay comes as the company continues to navigate its operational and financial complexities. Akso Health Group is a global provider of advanced robotic devices used in physical rehabilitation, incorporating visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training. The company has been actively working with its auditors and advisors to ensure compliance with regulatory requirements [2].

Despite the delay, the company remains focused on its strategic initiatives. Akso Health Group has seen growing potential in its personal health segment, specifically the Ekso Indigo personal exoskeleton, a robotic mobility device. Personal health product revenues grew more than 50% in the first six months of 2025, with expectations of reaching 25% of total company revenue this year. The company has also partnered with various healthcare enterprises to navigate market access complexities and has launched a virtual platform for continuing education courses for physical therapists [3].

The delay in filing the annual report does not have an immediate impact on the company's listing or trading on Nasdaq. Investors are advised to closely monitor the company's progress and the expected filing date for further updates.

References:

[1] https://www.barchart.com/stocks/quotes/AHG/opinion/100-200-Day-MA-Crossover/strategy-charts
[2] https://www.stocktitan.net/news/DHAI/dih-holding-us-inc-receives-notification-of-deficiency-from-nasdaq-mrc0exf2m1tg.html
[3] https://www.pressdemocrat.com/article/north-bay/ekso-bionics-q2-2025/?ref=home-business